Are there risks for lung cancer patients to undergo lung tissue biopsy? There are certain risks

There are certain risks for lung cancer patients to undergo puncture biopsy, such as inducing pneumothorax, bleeding, air embolism and other adverse symptoms. However, this risk factor is relatively low.

The occurrence of lung cancer has caused serious harm to the patient's health. So, are there any risks for lung cancer patients to undergo lung tissue puncture biopsy? Let's find out below.
There are certain risks for lung cancer patients to undergo lung tissue puncture biopsy. After all, puncture biopsy is an invasive examination, which inevitably has certain risks, big or small. The risks induced by this examination usually include: bleeding, pneumothorax, air embolism, etc.
However, generally speaking, the probability of these adverse symptoms occurring is relatively low, and as long as standardized operations are performed, they are unlikely to occur.
In fact, in clinical practice, many patients are worried about whether this puncture biopsy method, which requires the puncture needle to be inserted into the patient's lungs, will cause bleeding, or will it puncture the lungs? Or will it cause tumor metastasis?
It is understandable that patients worry about these things, after all, most patients lack basic medical knowledge. However, after countless clinical trials, puncture biopsy can be said to be absolutely safe, and the main standardized operation will not harm the patient's health.